DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia

DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia

- Final stage in licensing OVM-200 from Oxford Vacmedix in the UK - DxVx plans to proceed its own clinical trials in Asia, including Korea and China SEOUL, South Korea, Nov. 24, 2023 /PRNewswire/ -- DxVx announces today that it will conduct its own...

menu
menu